Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial
Journal of Clinical Oncology · 20.05.2024 · 42 (15) · 1799-1809
DOI: 10.1200/jco.23.01019 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.05.2024. Verfasst von Robert S Fichtinger und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands. Hauptthemen laut MEDLINE: Hepatectomy, Laparoscopy, Liver Neoplasms, Quality of Life. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cancer Research UK.
Abstract (Originalsprache)
PURPOSE To compare outcomes after laparoscopic versus open major liver resection (hemihepatectomy) mainly for primary or metastatic cancer. The primary outcome measure was time to functional recovery. Secondary outcomes included morbidity, quality of life (QoL), and for those with cancer, resection margin status and time to adjuvant systemic therapy. PATIENTS AND METHODS This was a multicenter, randomized controlled, patient-blinded, superiority trial on adult patients undergoing hemihepatectomy. Patients were recruited from 16 hospitals in Europe between November 2013 and December 2018. RESULTS Of the 352 randomly assigned patients, 332 patients (94.3%) underwent surgery (laparoscopic, n = 166 and open, n = 166) and comprised the analysis population. The median time to functional recovery was 4 days (IQR, 3-5; range, 1-30) for laparoscopic hemihepatectomy versus 5 days (IQR, 4-6; range, 1-33) for open hemihepatectomy (difference, –17.5% [96% CI, –25.6 to –8.4]; P < .001). There was no difference in major complications (laparoscopic 24/166 [14.5%] v open 28/166 [16.9%]; odds ratio [OR], 0.84; P = .58). Regarding QoL, both global health status (difference, 3.2 points; P < .001) and body image (difference, 0.9 points; P < .001) scored significantly higher in the laparoscopic group. For the 281 (84.6%) patients with cancer, R0 resection margin status was similar (laparoscopic 106 [77.9%] v open 122 patients [84.1%], OR, 0.60; P = .14) with a shorter time to adjuvant systemic therapy in the laparoscopic group (46.5 days v 62.8 days, hazard ratio, 2.20; P = .009). CONCLUSION Among patients undergoing hemihepatectomy, the laparoscopic approach resulted in a shorter time to functional recovery compared with open surgery. In addition, it was associated with a better QoL, and in patients with cancer, a shorter time to adjuvant systemic therapy with no adverse impact on cancer outcomes observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands.
- Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
- Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.
- Department of Surgery, Southampton University Hospital NHS Foundation Trust, Southampton, United Kingdom.
- Department of Surgery, Poliambulanza Hospital, Brescia, Italy.
- Division of HPB, Minimally Invasive and Robotic Surgery, Department of Clinical Medicine and Surgery, Transplantation Service, Federico II University, Naples, Italy.
ORCID-Profile: Robert S Fichtinger, Mohammed Abu Hilal, Roberto I Troisi, Robert P Sutcliffe, Marc G Besselink, Somaiah Aroori, Krishna V Menon, Bjørn Edwin, Mathieu D'Hondt, Valerio Lucidi, Tom F Ulmer, Zahir Soonawalla, Gregory Sergeant, Bram Olij, Francesca Ratti, Christoph Kuemmerli, Vincenzo Scuderi, Frederik Berrevoet, Aude Vanlander, Ravi Marudanayagam, Pieter Tanis, Maxime J L Dewulf, Zina Eminton, Merel L Kimman, Lloyd Brandts, Ulf P Neumann, Åsmund A Fretland, Siân A Pugh, Gerard J P van Breukelen, John N Primrose, Ronald M van Dam
Förderung
- Cancer Research UK
Zitieren
APA
Fichtinger, R. S., Aldrighetti, L. A., Abu Hilal, M., Troisi, R. I., Sutcliffe, R. P., Besselink, M. G., Aroori, S., Menon, K. V., Edwin, B., D'Hondt, M., Lucidi, V., Ulmer, T. F., Díaz-Nieto, R., Soonawalla, Z., White, S., Sergeant, G., Olij, B., Ratti, F., Kuemmerli, C., …, & ORANGE II PLUS Collaborative (2024). Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial. Journal of Clinical Oncology, 42(15), 1799-1809. https://doi.org/10.1200/jco.23.01019
Vancouver
Fichtinger RS, Aldrighetti LA, Abu Hilal M, Troisi RI, Sutcliffe RP, Besselink MG, et al. Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial. Journal of Clinical Oncology. 2024;42(15):1799-1809. doi:10.1200/jco.23.01019
BibTeX
@article{Fichtinger2024,
author = {Fichtinger, Robert S and Aldrighetti, Luca A and Abu Hilal, Mohammed and Troisi, Roberto I and Sutcliffe, Robert P and Besselink, Marc G and Aroori, Somaiah and Menon, Krishna V and Edwin, Bjørn and D'Hondt, Mathieu and Lucidi, Valerio and Ulmer, Tom F and Díaz-Nieto, Rafael and Soonawalla, Zahir and White, Steve and Sergeant, Gregory and Olij, Bram and Ratti, Francesca and Kuemmerli, Christoph and Scuderi, Vincenzo and Berrevoet, Frederik and Vanlander, Aude and Marudanayagam, Ravi and Tanis, Pieter and Dewulf, Maxime J L and Dejong, Cornelis H C and Eminton, Zina and Kimman, Merel L and Brandts, Lloyd and Neumann, Ulf P and Fretland, Åsmund A and Pugh, Siân A and van Breukelen, Gerard J P and Primrose, John N and van Dam, Ronald M and ORANGE II PLUS Collaborative, ORANGE II PLUS Collaborative},
title = {Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial},
journal = {Journal of Clinical Oncology},
year = {2024},
volume = {42},
number = {15},
pages = {1799--1809},
doi = {10.1200/jco.23.01019}
}
EUVIMED